43 results
6-K
EX-99.2
KMDA
Kamada Ltd
6 Mar 24
Report of Foreign Private Issuer
7:10am
or maintaining U.S. Food and Drug Administration, European Medicines Agency and other regulatory authority approvals, the regulatory environment, restrains
6-K
EX-99.2
KMDA
Kamada Ltd
13 Nov 23
Report of Foreign Private Issuer
7:00am
Administration, European Medicines Agency and other regulatory authority approvals, the regulatory environment, restrains related to third parties’ IP
6-K
EX-99.2
KMDA
Kamada Ltd
16 Aug 23
Report of Foreign Private Issuer
7:00am
Administration, European Medicines Agency and other regulatory authority approvals, the regulatory environment, restrains related to third parties’ IP
6-K/A
EX-99.2
KMDA
Kamada Ltd
24 May 23
Current report (foreign) (amended)
4:05pm
governmental or local authority now in effect relating to human health and safety, the environment, recycling, or to pollutants, contaminants, wastes
6-K
EX-99.2
qcaeec1 s5rht63u
24 May 23
Kamada Reports Strong First Quarter 2023 Financial Results; Reiterates
8:00am
6-K/A
EX-99.1
2smi kwy3si96aat0
17 Nov 22
Current report (foreign) (amended)
1:08pm
6-K
EX-99.1
sfye43 w9yy9e3ziyc
8 Nov 22
Notice of Annual General Meeting of Shareholders
7:02am
6-K
EX-99.2
d9z0cfj06djqkjy
22 Nov 21
Report of Foreign Private Issuer
7:06am
6-K
EX-99.1
jm9f699m
12 May 21
Kamada Reports First Quarter 2021 Financial Results, Recent Achievements and Corporate Development Activities
7:06am
6-K
EX-99.1
w9f3yx
10 Feb 21
Kamada Reports Fourth Quarter and Fiscal Year 2020 Financial Results, Recent Achievements and Corporate Development Activities
7:00am
6-K
EX-99.1
f17y7ay3
29 Oct 20
Report of Foreign Private Issuer
5:00pm
6-K
EX-99.1
xrqaza7ndp7y0jhhcrgi
13 Feb 20
Report of Foreign Private Issuer
11:06am
6-K
EX-99.2
gypzp6nsxe6h
21 Jan 20
Kamada Announces $25 Million Private Placement with FIMI Opportunity Fund
7:00am